Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice

Oncogene

Volumn 25, Issue 18, 2006, Pages 2575-2587

  Chen, E ^a,b   Lim, M S ^c   Rosic Kablar, S ^b   Liu, J ^a,b   Jolicoeur, P ^d   Dube I D ^a,b   Hough, M R ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Aneuploidy; Homeobox; HOX11; Insertional mutagenesis

Indexed keywords

ANEUGEN; BROXURIDINE; CELL CYCLE PROTEIN 20; COLCHICINE; CYCLIN A; CYCLIN B1; DEMECOLCINE; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN HOX11; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANEUPLOIDY; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CHROMOSOME SEGREGATION; CONTROLLED STUDY; CYTOKINESIS; DNA CONTENT; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INSERTION; GENE OVEREXPRESSION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HOMEOBOX; HOX11 GENE; INCIDENCE; KARYOTYPE; MICRONUCLEUS TEST; MITOSIS; MITOSIS INHIBITION; MITOSIS SPINDLE; MOUSE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROVIRUS; REGULATORY MECHANISM; T CELL LEUKEMIA; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; B-LYMPHOCYTES; BROMODEOXYURIDINE; CELL CYCLE PROTEINS; CYCLIN A; CYCLIN B; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, B-CELL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOTIC SPINDLE APPARATUS; MUTAGENESIS, INSERTIONAL; PROVIRUSES; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA; MUS MUSCULUS;

EID: 33646384607     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209285     Document Type: Article

References (36)

1. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG. (2004). Nucl Acids Res 32: D523-D527.
2. Asnafi V, Beldjord K, Libura M, Villarese P, Millien C, Ballerini P et al. (2004). Blood 104: 4173-4180.
3. Asnafi V, Buzyn A, Thomas X, Huguet F, Vey N, Boiron JM et al. (2005). Blood 105: 3072-3078.
4. Aziz DC, Hanna Z, Jolicoeur P. (1989). Nature 338: 505-508.
5. Berns A. (1991). J Cell Biochem 47: 130-135.
6. Bourner RD, Parry EM, Parry JM. (1998). Mutat Res 404: 191-197.
7. Casabianca A, Orlandi C, Fraternale A, Magnani M. (2003). J Virol Methods 110: 81-90.
8. Chattopadhyay SK, Morse HC, Makino III M, Ruscetti SK, Hartley JW. (1989). Proc Natl Acad Sci USA 86: 3862-3866.
9. Diamond RA, DeMaggio S (eds). Living Color: Protocols in Flow Cytometry and Cell Sorting, Springer Lab Manual. Springer: Berlin, 2000.
10. Dubé ID, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G et al. (1991). Blood 78: 2996-3003.
11. Dubé ID, Raimondi SC, Pi D, Kalousek DK. (1986). Blood 67: 1181-1184.
12. Erkeland SJ, Valkhof M, Heijmans-Antonissen C, van Hoven-Beijen A, Delwel R, Hermans MH et al. (2004). J Virol 78: 1971-1980.
13. Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH et al. (2004). Lancet 363: 535-536.
14. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. (2002). Cancer Cell 1: 75-87.
15. Hough MR, Reis MD, Singaraja R, Bryce DM, Kamel-Reid S, Dardick I et al. (1998). Proc Natl Acad Sci USA 95: 13853-13858.
16. Huang M, Simard C, Jolicoeur P. (1989). Science 246: 1614-1617.
17. Huang M, Simard C, Jolicoeur P. (1992). J Virol 66: 2398-2406.
18. Huang M, Simard C, Kay DG, Jolicoeur P. (1991). J Virol 65: 6562-6571.
19. Huang M, Takac M, Kozak CA, Jolicoeur P. (1995). J Virol 69: 4069-4078.
20. Hwang HC, Martins CP, Bronkhorst Y, Randel E, Berns A, Fero M et al. (2002). Proc Natl Acad Sci USA 99: 11293-11298.
21. Iwasaki M, Kuwata T, Yamazaki Y, Jenkins NA, Copeland NG, Osato M et al. (2004). Blood 105: 784-793.
22. Jonkers J, Berns A. (1996). Biochim Biophys Acta 1287: 29-57.
23. Kawabe T, Muslin AJ, Korsmeyer SJ. (1997). Nature 385: 454-458.
24. Kees UR, Heerema NA, Kumar R, Watt PM, Baker DL, La MK et al. (2003). Leukemia 17: 887-893.
25. Kim R, Trubetskoy A, Suzuki T, Jenkins NA, Copeland NG, Lenz J. (2003). J Virol 77: 2056-2062.
26. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A et al. (2005). Nat Cell Biol 7: 126-136.
27. Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, Nakamura T et al. (1999). Nat Genet 23: 348-353.
28. Lichty BD, Ackland-Snow J, Noble L, Kamel-Reid S, Dube ID. (1995). Leuk Lymphoma 16: 209-215.
29. Mauvieux L, Leymarie V, Helias C, Perrusson N, Falkenrodt A, Lioure B et al. (2002). Leukemia 16: 2417-2422.
30. Morse HC, Anver III MR, Fredrickson TN, Haines DC, Harris AW, Harris NL et al. (2002). Blood 100: 246-258.
31. Muehlbauer PA, Schuler MJ. (2005). Mutat Res 585: 156-169.
32. Rao H, Uhlmann F, Nasmyth K, Varshavsky A. (2001). Nature 410: 955-959.
33. Riz I, Hawley RG. (2005). Oncogene 14: 5561-5575.
34. Rosic-Kablar S, Chan K, Reis MD, Dube ID, Hough MR. (2000). Proc Natl Acad Sci USA 97: 13300-13305.
35. Shin MS, Fredrickson TN, Hartley JW, Suzuki T, Agaki K, Morse III HC. (2004). Cancer Res 64: 4419-4427.
36. Varshavsky A. (1996). Proc Natl Acad Sci USA 93: 12142-12149.